Terms: = Cervical cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717
39 results:
1. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
[TBL] [Abstract] [Full Text] [Related]
2. [Etiological analysis of a patient with multiple primary malignant neoplasms].
Shi PJ; Li YB; Xiao HP
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(47):3848-3851. PubMed ID: 38123227
[TBL] [Abstract] [Full Text] [Related]
3.
Wen B; Luo L; Zeng Z; Luo X
J Int Med Res; 2023 Nov; 51(11):3000605231208582. PubMed ID: 37950670
[TBL] [Abstract] [Full Text] [Related]
4. DUSP1 regulates the jak2/STAT3 signaling pathway through targeting miR-21 in cervical cancer cells.
Chen H; Ren S; Wan H; Wei W; Luo Y; Cai M
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):40-44. PubMed ID: 37715430
[TBL] [Abstract] [Full Text] [Related]
5. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
6. Epidemiological Trends and Attributable Risk Burden of cervical cancer: An Observational Study from 1990 to 2019.
Yao H; Yan C; Qiumin H; Li Z; Jiao A; Xin L; Hong L
Int J Clin Pract; 2022; 2022():3356431. PubMed ID: 36263235
[TBL] [Abstract] [Full Text] [Related]
7. LPCAT1 functions as an oncogene in cervical cancer through mediating jak2/STAT3 signaling.
Gao F; Chen J; Zhang T; Liu N
Exp Cell Res; 2022 Dec; 421(1):113360. PubMed ID: 36122769
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic cervical cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
Xu Q; Wang J; Sun Y; Lin Y; Liu J; Zhuo Y; Huang Z; Huang S; Chen Y; Chen L; Ke M; Li L; Li Z; Pan J; Song Y; Liu R; Chen C
J Clin Oncol; 2022 Jun; 40(16):1795-1805. PubMed ID: 35192397
[TBL] [Abstract] [Full Text] [Related]
9. Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the jak2/STAT3 signaling pathway.
Lei H; Shi J; Teng Y; Song C; Zou L; Ye F; Zhang H
Adv Clin Exp Med; 2021 Jul; 30(7):727-736. PubMed ID: 34118143
[TBL] [Abstract] [Full Text] [Related]
10. cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels.
Zhou C; Wei W; Ma J; Yang Y; Liang L; Zhang Y; Wang Z; Chen X; Huang L; Wang W; Wu S
Mol Ther; 2021 Apr; 29(4):1512-1528. PubMed ID: 33388421
[TBL] [Abstract] [Full Text] [Related]
11. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
13. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
[TBL] [Abstract] [Full Text] [Related]
14. miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer.
Hu QL; Xu ZP; Lan YF; Li B
Kaohsiung J Med Sci; 2020 May; 36(5):328-335. PubMed ID: 31889428
[TBL] [Abstract] [Full Text] [Related]
15. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.
Kashyap VK; Dan N; Chauhan N; Wang Q; Setua S; Nagesh PKB; Malik S; Batra V; Yallapu MM; Miller DD; Li W; Hafeez BB; Jaggi M; Chauhan SC
Cancer Lett; 2020 Feb; 470():64-74. PubMed ID: 31809801
[TBL] [Abstract] [Full Text] [Related]
16. Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study.
Xiao Y; Cheng H; Wang L; Yu X
J Gynecol Oncol; 2020 Jan; 31(1):e2. PubMed ID: 31788992
[TBL] [Abstract] [Full Text] [Related]
17. MUC16 facilitates cervical cancer progression via jak2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.
Shen H; Guo M; Wang L; Cui X
Genes Genomics; 2020 Feb; 42(2):127-133. PubMed ID: 31736008
[TBL] [Abstract] [Full Text] [Related]
18. REX1 promotes EMT-induced cell metastasis by activating the jak2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
Zeng YT; Liu XF; Yang WT; Zheng PS
Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
[TBL] [Abstract] [Full Text] [Related]
19. MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of jak2.
Wei H; He WR; Chen KM; Wang XW; Yi CJ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5640-5647. PubMed ID: 31298355
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
Zhang YY; Li M; Xu YD; Shang J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3664-3671. PubMed ID: 31114991
[TBL] [Abstract] [Full Text] [Related]
[Next]
